-
Company Insights
NewAfterpay – Competitor Profile
Afterpay offers buy now pay later (BNPL) services, enabling consumers to pay for purchases in installments. Initially an online-only payment solution, it is now also available for in-store purchases in select countries. Founded in Australia in October 2014, Afterpay subsequently expanded its operations by launching in New Zealand (May 2017), the US (May 2018), the UK (under the Clearpay brand name) (August 2018), and Canada (August 2020). In addition to the UK, Clearpay was also available in other European markets...
-
Sector Analysis
NewUnited States (US) Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to 2028
Reasons to buy the ‘US Construction’ market sizing report: Get a comprehensive analysis of the construction industry in the US. Access the historical and forecast valuations of the US construction industry along with details of key growth drivers. Identify the sectors and sub-sectors within the US construction market. Examine the mega-project pipeline, including breakdowns by development stage across all sectors. Assess the projected spending on projects in the existing pipeline. Learn about the major projects in the US construction market, in...
-
Sector Analysis
NewUnited States (US) Retail Consumer Insights – Spending Intentions and Shopping Habits, 2024
US Retail Consumer Insights Report Overview More than 46% of consumers believe the economy will worsen over the next six months. Thus, consumers intend to cut back on retail goods and services. Furthermore, many US consumers stated that they are switching to economic brand alternatives to cope with cost pressures. This means that retailers must have a broad pricing architecture of brands stocked in-store to entice shoppers to trade up and down within the same retailer. The ‘US Retail Consumer...
-
Sector Analysis
NewEurope Fibercos and Towercos Market Dynamics and Opportunities
Europe Fibercos and Towercos Market Report Overview Fibercos and towercos in Europe are heading toward organic growth strategies for controlling debts and sustaining rollout targets. Furthermore, infrastructure companies are trying to reduce their carbon emissions by generating power to support their operations. Large consumer base and favorable regulatory environment in Europe have made the region the most viable choice for investments from international telecommunications players. Additionally, a surge in demand for high-speed connectivity in the European economies is encouraging telecom...
-
Sector Analysis
NewRussia Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to 2028
Following an annual growth of 7% in 2023, GlobalData expects the Russian construction industry to contract by 4.7% in real terms in 2024, owing to rising Western sanctions, coupled with rising material costs and interest rates, a growing budget deficit, falling government revenues and an exodus of skilled workers. Average construction material prices increased by 3% year-on-year (YoY) in 2023 according to Federal State Statistics Service (Rosstat). In addition, the price cap on Russian crude oil set by the Group...
-
Product Insights
Candidiasis – Drugs In Development, 2023
Global Markets Direct’s, ‘Candidiasis - Drugs In Development, 2023’, provides an overview of the Candidiasis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Candidiasis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Methicillin-Resistant Staphylococcus aureus (MRSA) Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Drugs In Development, 2023’, provides an overview of the Methicillin-Resistant Staphylococcus aureus (MRSA) Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Methicillin-Resistant Staphylococcus aureus (MRSA) Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Mycoses – Drugs In Development, 2023
Global Markets Direct’s, ‘Mycoses - Drugs In Development, 2023’, provides an overview of the Mycoses pipeline landscape. The report provides comprehensive information on the therapeutics under development for Mycoses, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Smallpox – Drugs In Development, 2023
Global Markets Direct’s, ‘Smallpox - Drugs In Development, 2023’, provides an overview of the Smallpox pipeline landscape. The report provides comprehensive information on the therapeutics under development for Smallpox, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Anterior Uveitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Anterior Uveitis - Drugs In Development, 2023’, provides an overview of the Anterior Uveitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Anterior Uveitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...